Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 132.50
0.00 (0.00%)
Jul 21, 2026, 8:00 AM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 112.19 million as of July 20, 2026. Its market cap has increased by 3.25% in one year.
Market Cap
112.19M
Enterprise Value
106.00M
Revenue
38.44M
Ranking
n/a
PE Ratio
1,156.58
Stock Price
132.50
ChartMarket Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 112.19M, an increase of 68.83%. That is a compound annual growth rate of 7.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 112.19M | 3.22% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 195.34B |
| GSK plc | 76.32B |
| Haleon | 32.88B |
| Smith & Nephew | 9.68B |
| Scancell Holdings | 137.51M |
| EKF Diagnostics Holdings | 108.49M |
| INSPECS Group | 98.62M |
| Faron Pharmaceuticals Oy | 91.98M |